Join the Lexapro group to help and get support from people like you.
Lexapro News
Antidepressant Use May Speed Up Cognitive Decline in Patients With Dementia
WEDNESDAY, March 5, 2025 – Current antidepressant use is associated with faster cognitive decline in patients with dementia, according to a study published online Feb. 25 in BMC Medicine. Minjia Mo,...
Antidepressants Might Accelerate Dementia Decline
TUESDAY, Feb. 25, 2025 (HealthDay news) – Antidepressants are frequently prescribed to people with dementia for symptoms like anxiety, depression, aggressiveness and sleeplessness. But a specific...
Could Antidepressants Give Memory a Boost?
MONDAY, Sept. 23, 2024 – Antidepressants have the potential to improve memory and thinking skills, a new study suggests. Some patients experienced a boost on brain tests after taking the SSRI...
FDA Medwatch Alert: Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: Drug Safety Communication - Use During Pregnancy and Potential Risk of Persistent Pulmonary Hypertension of the Newborn
Including Celexa (citalopram); Lexapro (escitalopram); Prozac, Sarafem, Symbyax (fluoxetine); Luvox, Luvox CR (fluvoxamine); Paxil, Paxil CR, Pexeva (paroxetine); Zoloft (sertraline); Viibryd...
FDA Medwatch Alert: Lexapro (escitalopram oxalate)
[Posted 02/16/2007] FDA informed consumers and healthcare professionals regarding the possible dangers of buying prescription medications online. Individuals who ordered Ambien, Xanax, Lexapro, and...
FDA Medwatch Alert: Lexapro (escitalopram)
[UPDATE 07/08/2005] FDA notified healthcare professionals about the availability of updated Healthcare Professional and Patient Information Sheets for antidepressant medications that were the subject...
FDA Medwatch Alert: Antidepressant Medication Products
[Posted 05/02/2007] FDA notified healthcare professionals that the Agency proposed that makers of all antidepressant medications update the existing black box warning on the prescribing information...
FDA Medwatch Alert: Selective Serotonin Reuptake Inhibitors (SSRIs) - Serotonin Syndrome
[Posted 07/19/2006] FDA notified healthcare professionals and consumers of new safety information regarding taking medications used to treat migraine headaches (triptans) together with certain types...
FDA Medwatch Alert: SSRIs and Treatment Challenges of Depression in Pregnancy
[Posted 07/19/2006] FDA notified healthcare professionals and consumers of important information from two recent studies that should be considered when making treatment decisions in pregnant women...
FDA Medwatch Alert: Public Health Advisory: Antidepressant Use in Children, Adolescents, and Adults
The FDA asked manufacturers of the following antidepressant drugs to include in their labeling a Warning statement that recommends close observation of adult and pediatric patients for worsening...
Further information
Related condition support groups
Anxiety, Major Depressive Disorder, Generalized Anxiety Disorder, Depression